Analysts Set Aemetis, Inc. (NASDAQ:AMTX) Price Target at $12.95

Aemetis, Inc. (NASDAQ:AMTX) has been assigned an average recommendation of “Moderate Buy” from the five ratings firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $12.95.

Several research analysts have recently commented on the company. StockNews.com raised Aemetis to a “sell” rating in a report on Friday, January 3rd. HC Wainwright reissued a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research note on Monday, December 23rd.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of AMTX. FMR LLC lifted its holdings in shares of Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after acquiring an additional 9,137 shares during the last quarter. Hutchinson Capital Management CA purchased a new stake in Aemetis during the second quarter valued at about $70,000. Barclays PLC grew its stake in shares of Aemetis by 274.6% during the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after buying an additional 34,816 shares during the last quarter. Rhumbline Advisers increased its holdings in shares of Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after buying an additional 50,528 shares during the period. Finally, Wellington Management Group LLP purchased a new position in shares of Aemetis in the third quarter worth about $177,000. 27.02% of the stock is currently owned by institutional investors.

Aemetis Price Performance

Shares of NASDAQ:AMTX opened at $2.87 on Monday. The firm has a fifty day moving average price of $3.28 and a two-hundred day moving average price of $2.97. The company has a market cap of $142.74 million, a price-to-earnings ratio of -1.27 and a beta of 1.47. Aemetis has a one year low of $2.10 and a one year high of $7.03.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same period in the prior year, the business posted ($0.59) EPS. Equities research analysts expect that Aemetis will post -2.02 EPS for the current fiscal year.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.